The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The CODEINE (SEE ALSO: CODEINE PHOSPHATE (CAS 52-28-8)) Drug Master File in Japan (CODEINE (SEE ALSO: CODEINE PHOSPHATE (CAS 52-28-8)) JDMF) empowers CODEINE (SEE ALSO: CODEINE PHOSPHATE (CAS 52-28-8)) API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the CODEINE (SEE ALSO: CODEINE PHOSPHATE (CAS 52-28-8)) JDMF during the approval evaluation for pharmaceutical products. At the time of CODEINE (SEE ALSO: CODEINE PHOSPHATE (CAS 52-28-8)) JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of CODEINE (SEE ALSO: CODEINE PHOSPHATE (CAS 52-28-8)) suppliers with JDMF on PharmaCompass.